HLA-G and neoplasm: The goal of this study is to determine whether the expression of HLA-G on tumor, along with soluble HLA-G production, may affect the clinical response of patients to immunotherapy, in terms of tumor response rate and progression-free/overall survival (www.clinicaltrials.gov accessed on 30 January 2022).